Bulgaria
BioMerieux SA (BMXMF) Q2 2024 Earnings Call Transcript Highlights: Strong Sales Growth and Strategic Advancements
Sales Growth: 10% sales growth in H1 2024, surpassing the 7% annual guidance.Non-Respiratory Panel Sales Growth: 19% in H1 2024.SPOTFIRE Sales: EUR33 million i